235 related articles for article (PubMed ID: 19753745)
1. Institutional policy on financial conflict of interest: objectivity in research.
Shalev M
Lab Anim (NY); 2003 Apr; 32(4):16-7. PubMed ID: 19753745
[No Abstract] [Full Text] [Related]
2. Zerhouni proposes major changes to NIH ethics program.
J Natl Cancer Inst; 2004 Jul; 96(14):1057. PubMed ID: 15265963
[No Abstract] [Full Text] [Related]
3. NerveCenter: Office of Inspector General warns NIH on lax COI oversight as many academic medical centers look inward.
Samson K
Ann Neurol; 2010 Mar; 67(3):A7-A10. PubMed ID: 20373337
[No Abstract] [Full Text] [Related]
4. Industry-sponsored clinical research: a broken system.
Angell M
JAMA; 2008 Sep; 300(9):1069-71. PubMed ID: 18768418
[No Abstract] [Full Text] [Related]
5. Financial conflicts of interest and the NIH.
Steinbrook R
N Engl J Med; 2004 Jan; 350(4):327-30. PubMed ID: 14736923
[No Abstract] [Full Text] [Related]
6. Academic-industrial relationships in the life sciences.
Blumenthal D
N Engl J Med; 2003 Dec; 349(25):2452-9. PubMed ID: 14681513
[No Abstract] [Full Text] [Related]
7. More regulation of industry-supported biomedical research: are we asking the right questions?
Fry-Revere S; Malmstrom DB
J Law Med Ethics; 2009; 37(3):420-30, 395. PubMed ID: 19723253
[TBL] [Abstract][Full Text] [Related]
8. The challenge for NIH ethics policies: preserving public trust and biomedical progress.
Bravo NR
Cleve Clin J Med; 2007 Mar; 74 Suppl 2():S29-31; discussion S32-7. PubMed ID: 17469471
[TBL] [Abstract][Full Text] [Related]
9. Managing financial conflict of interest in biomedical research.
Rockey SJ; Collins FS
JAMA; 2010 Jun; 303(23):2400-2. PubMed ID: 20498237
[No Abstract] [Full Text] [Related]
10. Interest in conflicts.
Cronstein BN
Clin Transl Sci; 2010 Apr; 3(2):52-3. PubMed ID: 20401172
[No Abstract] [Full Text] [Related]
11. Biomedical research: facing the opposition.
Check E
Nature; 2006 May; 441(7089):17-9. PubMed ID: 16672943
[No Abstract] [Full Text] [Related]
12. Expanding disclosure of conflicts of interest: the views of stakeholders.
Brody BA; Anderson C; McCrary SV; McCullough L; Morgan R; Wray N
IRB; 2003; 25(1):1-8. PubMed ID: 12833897
[No Abstract] [Full Text] [Related]
13. [For and against: does sponsoring impede the growth of knowledge in medicine?].
Finzen A; Fritze J
Psychiatr Prax; 2007 May; 34(4):162-4. PubMed ID: 17520527
[No Abstract] [Full Text] [Related]
14. NIH set to tighten financial rules for researchers.
Wadman M
Nature; 2010 May; 465(7297):407. PubMed ID: 20505703
[No Abstract] [Full Text] [Related]
15. Temporary insanity?
Barie PS
Surg Infect (Larchmt); 2005; 6(2):181-4. PubMed ID: 16128624
[No Abstract] [Full Text] [Related]
16. Is it really all about the money? Reconsidering non-financial interests in medical research.
Saver RS
J Law Med Ethics; 2012; 40(3):467-81. PubMed ID: 23061574
[TBL] [Abstract][Full Text] [Related]
17. Is industry money the root of all conflicts of interest in biomedical research?
Caplan AL
Ann Emerg Med; 2012 Feb; 59(2):87-8. PubMed ID: 21459479
[No Abstract] [Full Text] [Related]
18. Research accountability and financial conflicts of interest in industry-sponsored clinical research: a review.
Tereskerz PM
Account Res; 2003; 10(3):137-58. PubMed ID: 14979317
[No Abstract] [Full Text] [Related]
19. Financial relationships of institutional review board members.
Miller FG
N Engl J Med; 2007 Mar; 356(9):965; author reply 965. PubMed ID: 17329710
[No Abstract] [Full Text] [Related]
20. Agency under siege.
Nature; 2005 Jul; 436(7049):304. PubMed ID: 16034377
[No Abstract] [Full Text] [Related]
[Next] [New Search]
